Vestal Point Capital, LP Jazz Pharmaceuticals PLC Transaction History
Vestal Point Capital, LP
- $1.21 Trillion
- Q1 2024
A detailed history of Vestal Point Capital, LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,100,000 shares of JAZZ stock, worth $117 Million. This represents 10.95% of its overall portfolio holdings.
Number of Shares
1,100,000
Previous 725,000
51.72%
Holding current value
$117 Million
Previous $89.2 Billion
48.54%
% of portfolio
10.95%
Previous 9.45%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
514Shares Held
57.1MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$755 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$688 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$263 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$254 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$160 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.69B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...